Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Methods Enzymol ; 587: 257-269, 2017.
Article in English | MEDLINE | ID: mdl-28253960

ABSTRACT

Autophagy is the major cellular process of degradation and is modulated by several signaling pathways. Phosphatidylinositol 3-kinase (PtdIns3K) class III (Vps34) and PtdIns3K class I regulate the autophagy pathway positively and negatively, respectively. Both classes of PtdIns3K participate in the synthesis of phosphatidylinositol 3-phosphate (PtdIns3P), which plays a crucial role in autophagosome biogenesis and membrane traffic. PtdIns3P is a membrane phospholipid that is associated with endogenous FYVE domain-containing proteins. Indeed, such interactions facilitate autophagosome fusion with lysosomes and subsequent cargo degradation. During starvation-induced autophagy, the expression of FYVE domain-containing proteins increases, and their binding to PtdIns3P is strengthened. Nonetheless, not all FYVE domain proteins are related to the induction of autophagy. This method report presents the quantification of PtdIns3P synthesis by using cells either transiently transfected with or stably expressing FYVE-dsRed.


Subject(s)
Autophagy , Microscopy, Fluorescence/methods , Molecular Biology/methods , Phosphatidylinositol Phosphates/biosynthesis , Recombinant Proteins/metabolism , Cell Line , Fluorescent Dyes/metabolism , Guanine Nucleotide Exchange Factors/genetics , Guanine Nucleotide Exchange Factors/metabolism , Humans , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Phosphatidylinositol Phosphates/analysis , Recombinant Proteins/analysis , Recombinant Proteins/genetics
2.
Mol Neurobiol ; 54(8): 6287-6303, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27714635

ABSTRACT

Mitochondria-associated membranes (MAMs) are structures that regulate physiological functions between endoplasmic reticulum (ER) and mitochondria in order to maintain calcium signaling and mitochondrial biogenesis. Several proteins located in MAMs, including those encoded by PARK genes and some of neurodegeneration-related proteins (huntingtin, presenilin, etc.), ensure this regulation. In this regard, MAM alteration is associated with neurodegenerative diseases such as Parkinson's (PD), Alzheimer's (AD), and Huntington's diseases (HD) and contributes to the appearance of the pathogenesis features, i.e., autophagy dysregulation, mitochondrial dysfunction, oxidative stress, and lately, neuronal death. Moreover,, ER stress and/or damaged mitochondria can be the cause of these disruptions. Therefore, ER-mitochondria contact structure and function are crucial to multiple cellular processes. This review is focused on the molecular interaction between ER and mitochondria indispensable to MAM formation and on MAM alteration-induced etiology of neurodegenerative diseases.


Subject(s)
Cell Death/physiology , Endoplasmic Reticulum/metabolism , Mitochondrial Membranes/metabolism , Oxidative Stress/physiology , Parkinson Disease/metabolism , Animals , Humans , Mitochondria/metabolism , Organelle Biogenesis
3.
Curr Med Chem ; 23(21): 2275-85, 2016.
Article in English | MEDLINE | ID: mdl-27237817

ABSTRACT

Pompe disease or glycogen storage disease type II (OMIM: 232300) is a lysosomal storage disorder resulting from a partial or total lack of acid alphaglucosidase, which may produce muscle weakness, gait abnormalities, or even death by respiratory failure. In the last decade, autophagy has been proposed as a mechanism involved in the severity of symptoms related to this disorder and as a potential therapeutic target to alleviate disease progression. This review summarizes the relationship between autophagy and Pompe disease, including what information has been recently discovered and what remains unclear.


Subject(s)
Autophagy , Glycogen Storage Disease Type II/pathology , Animals , Disease Models, Animal , Enzyme Replacement Therapy , Glycogen Storage Disease Type II/metabolism , Glycogen Storage Disease Type II/therapy , Humans , Microtubule-Associated Proteins/metabolism , Mitochondria/metabolism , Muscle, Skeletal/metabolism , alpha-Glucosidases/genetics , alpha-Glucosidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...